Down-Regulation of ECRG4, a Candidate Tumor Suppressor Gene, in Human Breast Cancer

Abstract

Our data suggest that ECRG4 is a candidate TSG in breast cancer, the expression of which may help improve the prognostication. If functional analyses confirm this TSG role, restoring ECRG4 expression in the tumor may represent a promising therapeutic approach.